Cargando…

The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major Depression

Detalles Bibliográficos
Autor principal:	Hashimoto, Kenji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean College of Neuropsychopharmacology 2014
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022771/ https://www.ncbi.nlm.nih.gov/pubmed/24851126 http://dx.doi.org/10.9758/cpn.2014.12.1.72

Ejemplares similares

Maintenance use of ketamine for treatment-resistant depression: an open-label pilot study
por: Barenboim, Ivan, et al.
Publicado: (2018)

S-(+)-ketamine-induced dissociative symptoms as a traumatic experience in patients with treatment-resistant depression
por: Correia-Melo, Fernanda S., et al.
Publicado: (2017)

Comparison of efficacy of ketamine versus thiopentone-assisted modified electroconvulsive therapy in major depression
por: Jagtiani, Amit, et al.
Publicado: (2020)

A BDNF Val66Met Polymorphism and Ketamine-induced Rapid Antidepressant Action
por: Hashimoto, Kenji
Publicado: (2012)

Ketamine: A Convulsant?
por: Kurdi, Madhuri S., et al.
Publicado: (2017)

Safety and efficacy of ketamine infusion in late onset depression, and conversion to treatment response
por: Srivastava, Shrikant, et al.
Publicado: (2015)

Ketamine with Propofol for Endoscopic Procedures
por: Bhalotra, Anju Romina
Publicado: (2018)

Is ketamine–propofol mixture (ketofol) an appropriate alternative induction agent for electroconvulsive therapy?
por: Firouzian, Abolfazl, et al.
Publicado: (2013)

Esketamine/ketamine for treatment-resistant depression
por: Lacerda, Acioly L.T.
Publicado: (2020)

Could ketamine be the answer to treating treatment-resistant major depressive disorder?
por: Ramadan, Abdullah Mohammed, et al.
Publicado: (2020)

Ketamine-induced QTc interval prolongation
por: Singh, Tejinder S. Swaran, et al.
Publicado: (2017)

Decreased bone mineral density in ovariectomized mice is ameliorated after subsequent repeated intermittent administration of (R)‐ketamine, but not (S)‐ketamine
por: Fujita, Yuko, et al.
Publicado: (2020)

Clinical Efficacy of Ketamine for Treatment-resistant Depression
por: Bratsos, Sosipatros, et al.
Publicado: (2019)

Magnesium in Ketamine Administration in Treatment-Resistant Depression
por: Górska, Natalia, et al.
Publicado: (2021)

Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder
por: Rong, Carola, et al.
Publicado: (2018)

Ketamine use in the COVID-19 era: be cautious!
por: Suri, Aditi, et al.
Publicado: (2020)

Comment on: “Low-Dose Ketamine for Outpatient Hysteroscopy.”
por: Raghuraman, M.S.
Publicado: (2021)

Combination of Nitrous Oxide with Isoflurane or Scopolamine for Treatment-resistant Major Depression
por: Yang, Chun, et al.
Publicado: (2015)

(R)-Ketamine Induces a Greater Increase in Prefrontal 5-HT Release Than (S)-Ketamine and Ketamine Metabolites via an AMPA Receptor-Independent Mechanism
por: Ago, Yukio, et al.
Publicado: (2019)

Ketamine as Add-On Treatment in Psychotic Treatment-Resistant Depression
por: Gałuszko-Węgielnik, Maria, et al.
Publicado: (2023)

As an analgesic ketamine versus fentanyl for total intravenous anesthesia
por: Ezici, Musa, et al.
Publicado: (2013)

Implementation of a perioperative ketamine shortage mitigation strategy
por: Dibridge, Julie, et al.
Publicado: (2020)

Ketamine as Monotherapy in Difficult Airways Is Not Ready for Prime Time
por: Driver, Brian E., et al.
Publicado: (2019)

Reduced functional bladder capacity associated with ketamine use
por: Ramos, Sergio de P., et al.
Publicado: (2019)

Intravenous ketamine and progressive cholangiopathy in COVID-19 patients
Publicado: (2021)

Ketamine, Interleukin-6, and Vasoplegia: Is Prevention the Best Medicine?
por: Ortoleva, Jamel P.
Publicado: (2023)

Nebulized ketamine in minor bronchoscopy procedures: A possibility
por: Bharti, Neha, et al.
Publicado: (2023)

Copper Concentrations in Ketamine Therapy for Treatment-Resistant Depression
por: Słupski, Jakub, et al.
Publicado: (2020)

Habenula Connectivity and Intravenous Ketamine in Treatment-Resistant Depression
por: Rivas-Grajales, Ana Maria, et al.
Publicado: (2020)

How effective are ketamine or esketamine in treatment-resistant depression?
por: Veluri, N., et al.
Publicado: (2021)

The Downstaging Concept in Treatment-Resistant Depression: Spotlight on Ketamine
por: Wilkowska, Alina, et al.
Publicado: (2022)

The Effect of Ketamine on Electrophysiological Connectivity in Major Depressive Disorder
por: Nugent, Allison C., et al.
Publicado: (2020)

Ketamine in Major Depressive Disorder: Mechanisms and Future Perspectives
por: Shin, Cheolmin, et al.
Publicado: (2020)

Ketamine for the treatment of major depression: a systematic review and meta-analysis
por: Nikolin, Stevan, et al.
Publicado: (2023)

Efficacy of ketamine therapy in the treatment of depression
por: Mandal, Suprio, et al.
Publicado: (2019)

Ketamine treatment for depression: a review
por: Yavi, Mani, et al.
Publicado: (2022)

Anaesthesia for thymectomy: Use of ketamine-dexmedetomidine without muscle relaxant
por: Varma, Shapna, et al.
Publicado: (2013)

Opioid Properties of Nitrous Oxide and Ketamine Contribute to Their Antidepressant Actions
por: Gillman, Mark A
Publicado: (2021)

(S)-Ketamine but Not (R)-Ketamine Shows Acute Effects on Depression-Like Behavior and Sleep-Wake Architecture in Rats
por: Koncz, Szabolcs, et al.
Publicado: (2023)

Regulation of neural responses to emotion perception by ketamine in individuals with treatment-resistant major depressive disorder
por: Murrough, J W, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8fgnl59ecu34s65gfdsmgtj2ra